Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.
about
GSK-3β as a target for protection against transient cerebral ischemiaGSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need.Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke.Potential biomarkers for predicting hemorrhagic transformation of ischemic stroke.β2-Adrenergic Receptor-Mediated HIF-1α Upregulation Mediates Blood Brain Barrier Damage in Acute Cerebral Ischemia.Decreased Lymphocyte-to-Monocyte Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Treated with Thrombolysis.Improving Cerebral Blood Flow after Arterial Recanalization: A Novel Therapeutic Strategy in Stroke.Worse Outcome in Stroke Patients Treated with rt-PA Without Early Reperfusion: Associated Factors.Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment.Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.Serum Hepatocyte Growth Factor Is Probably Associated With 3-Month Prognosis of Acute Ischemic Stroke.Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke.Carbon monoxide-releasing molecule-3 protects against ischemic stroke by suppressing neuroinflammation and alleviating blood-brain barrier disruption.Ultrastructural Characteristics of Neuronal Death and White Matter Injury in Mouse Brain Tissues After Intracerebral Hemorrhage: Coexistence of Ferroptosis, Autophagy, and NecrosisRosuvastatin Reduces Neuroinflammation in the Hemorrhagic Transformation After rt-PA Treatment in a Mouse Model of Experimental StrokeCombination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator
P2860
Q33702971-462579C6-F51C-4A0E-BC4C-4B0120D28A08Q34505250-A251EED3-FC5D-48B6-87A9-ADC6FEB0E1A0Q36022319-D5D56DB0-EB25-426D-98C9-DADD90C8CDBEQ37640874-07B18FB0-2CE2-4E38-B760-5DC2BAC785BAQ39108088-97B5CD7C-A956-4B62-8763-9D78DFF1BB8CQ39447215-6CB194DC-8372-4AFE-8C03-B635C4972C2DQ41430066-108F16B8-5F21-4890-8053-09D977CB32CAQ47134463-B6382FAD-5B4D-4610-9F99-B4E223D5E095Q47170593-9D5C934F-5040-4E44-B5AE-A3A17EEABE0BQ47223299-812A7AF9-F918-4507-A1BA-752BF2C45183Q47906782-737F13B9-C432-44EF-BF21-08DC1528C3B0Q47919801-1FADD18C-2427-40C1-84E1-2346A3C54D7FQ50101931-B28CFD35-1E91-4CC1-A5EC-AFAA944FB83AQ50986080-52D1A6F2-FB08-4717-BEEC-F1D37CC63B94Q55452849-3FBC35F2-3096-4733-BF95-A38727A31C29Q57175645-4722BDC3-24B5-4F9C-8021-3C6AC612B133Q58803460-FE4C82B8-B116-4D63-9ADC-2E6D1F24B68AQ59137588-2756E677-81C3-4E8F-9F1C-49A1BD9C4A4E
P2860
Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hemorrhagic Transformation aft ...... nisms, Models, and Biomarkers.
@ast
Hemorrhagic Transformation aft ...... nisms, Models, and Biomarkers.
@en
type
label
Hemorrhagic Transformation aft ...... nisms, Models, and Biomarkers.
@ast
Hemorrhagic Transformation aft ...... nisms, Models, and Biomarkers.
@en
prefLabel
Hemorrhagic Transformation aft ...... nisms, Models, and Biomarkers.
@ast
Hemorrhagic Transformation aft ...... nisms, Models, and Biomarkers.
@en
P2093
P2860
P1476
Hemorrhagic Transformation aft ...... nisms, Models, and Biomarkers.
@en
P2093
Mingchang Li
Qianxue Chen
P2860
P2888
P304
P356
10.1007/S12035-014-8952-X
P577
2014-11-04T00:00:00Z